ESMO 2023: A new option for thyroid cancer
- 02-11-2023
- Thyroid Cancer
- Expert Interview
- Video
Host:
Dr. Shreeya Nanda
Senior Clinical Content Manager, Springer Medicine
Dr. Laura Locati comments on the LIBRETTO-531 study of selpercatinib in previously untreated RET-mutant medullary thyroid carcinoma, which has provided a new treatment option for this patient population.
Speaker
- Dr. Laura Locati
University of Pavia, Italy